Logo-apb
Adv Pharm Bull. 2020;10(3): 444-451.
doi: 10.34172/apb.2020.054
PMID: 32665904
PMCID: PMC7335988
Scopus ID: 85088614001
  Abstract View: 1765
  PDF Download: 882
  Full Text View: 291

Research Article

miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1

Solmaz Shirjang 1 ORCID logo, Behzad Mansoori 1,2,3, Ali Mohammadi 1, Neda Shajari 4, Pascal H.G. Duijf 5, Souzan Najafi 1, Fereydoon Abedi Gaballu 1, Katayoon Nofouzi 6, Behzad Baradaran 1* ORCID logo

1 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark.
4 Department of Immunology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran.
5 University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Australia.
6 Department of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
*Corresponding Author: *Corresponding Author: Behzad Baradaran, Tel: +98 41 33371440 Fax: +98 41 33371311, Email: , Email: baradaranb@tbzmed.ac.ir

Abstract

Purpose: Based on WHO report, colorectal cancer (CRC) is the second cause of death among patients with cancer worldwide. Dysregulation of miRNAs expressions has been demonstrated in different human cancers, especially CRC. Studies have shown that miR-330 could act as both TS-miR and/or oncomiR in different types of cancers. BACH1 is also identified as a transcription factor, which is involved in ontogenesis. In this study, we evaluated the CRC suppression via silencing of BACH1 by small silencer molecule called miR-330.

Methods: Firstly, we analyzed the BACH1, miR-330-3p and miR-330-5p expressions according to the colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) project established from a patient of the colon and rectal cancer patients in The Cancer Genome Atlas (TCGA) database. The targeting of BACH1 via miR-330 in human CRC cells was evaluated by Vejnar bioinformatics methods, and confirmed by qRT-PCR and western blot analysis. Proliferation was performed by MTT assay. The MMP9, CXCR4, and VEGFR proteins were measured by western blotting.

Results: The analysis of BACH1, miR-330-3p, and miR-330-5p expressions according to the COAD and READ projects showed that BACH1 was overexpressed, but miR-330-3p and miR330-5p were reduced in CRC tumors compared to normal controls. The miR-330 induction prevented proliferation of CRC cell by targeting BACH1 mRNA, which represses MMP9, C-X-C chemokine receptor type 4 (CXCR4), and vascular endothelial growth factor receptor (VEGFR) proteins expressions.

Conclusion: Our results suggested that BACH1 is a potential target for miR-330 in CRC cells. The miR-330 induction inhibits CRC cells proliferation by suppressing BACH1 expression in posttranscriptional level. It was suggested that targeting of BACH1 via miRNA such as miR-330 could be a valid strategy in the field of CRC targeted therapy via modulating the oncogenic signaling pathway.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1766

Your browser does not support the canvas element.


PDF Download: 882

Your browser does not support the canvas element.


Full Text View: 291

Your browser does not support the canvas element.

Submitted: 28 Aug 2018
Revision: 28 Nov 2019
Accepted: 08 Dec 2019
ePublished: 11 May 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)